Starting from indole-based hepatitis C virus (HCV) NS5B polymerase inhibitor lead compound 1, structure modifications were performed at multiple indole substituents to improve potency and pharmacokinetic (PK) properties. Bicyclic quinazolinone was found to be the best substituent at indole nitrogen, while 4,5-furanylindole was identified as the best core. Compound 11 demonstrated excellent potency. Its C2 N,N-dimethylaminoethyl ester prodrug 12 (SCH 900188) demonstrated significant improvement in PK and was selected as the development candidate.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027611 | PMC |
| http://dx.doi.org/10.1021/ml400192w | DOI Listing |
Publication Analysis
Top Keywords
sch 900188
8
hepatitis virus
8
ns5b polymerase
8
polymerase inhibitor
8
development candidate
8
discovery sch
4
900188 potent
4
potent hepatitis
4
virus ns5b
4
inhibitor prodrug
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!